We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current JSPR market cap is 366.35M. The company's latest EPS is USD -4.2794 and P/E is -5.70.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.95M | -17.83M | -19.36M | -17.73M | -15.07M |
| Net Income | -14.26M | -16.08M | -17.54M | -16.58M | -13.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -136k | -935k | -36.83M | -51.2M | -68.86M |
| Net Income | 2k | -591k | -30.64M | -37.69M | -64.47M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 138.76M | 124.17M | 110.41M | 94.89M | 125.96M |
| Total Liabilities | 13.56M | 13.97M | 16.27M | 16.45M | 12.73M |
| Total Equity | 125.2M | 110.21M | 94.13M | 78.44M | 113.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 101.69M | 101.26M | 93.65M | 48.36M | 94.89M |
| Total Liabilities | 3.61M | 3.77M | 24.14M | 12.37M | 16.45M |
| Total Equity | 5M | 5M | 69.52M | 35.99M | 78.44M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.34M | -23.61M | -35.59M | -52.07M | -15.74M |
| Investing | -26k | -37k | -37k | -267k | -25k |
| Financing | 101.51M | 101.21M | 101.24M | 100.97M | 47.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -367k | -641k | -33.68M | -45.86M | -52.07M |
| Investing | -100M | 198k | -2.43M | -576k | -267k |
| Financing | 101.58M | N/A | 100.97M | 55k | 100.97M |
| Market Cap | 366.35M |
| Price to Earnings Ratio | -5.70 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.23 |
| Price to Book Ratio | 4.68 |
| Dividend Yield | - |
| Shares Outstanding | 15.06M |
| Average Volume (1 week) | 84.85k |
| Average Volume (1 Month) | 103.36k |
| 52 Week Change | 70.07% |
| 52 Week High | 31.01 |
| 52 Week Low | 4.00 |
| Spread (Intraday) | 0.85 (3.44%) |
| Company Name | Jasper Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.jaspertherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
